Ruthenium, dichloro[(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene](1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]decane-κP7)-;RAPTA-C;RAPTAC,RAPTA C
用途
Anticancer agent; anti-angiogenic agent; inhibits tumor growth by suppressing angiogenesis; exhibits anti-metastatic, anti-angiogenic, and antitumor activities by modulating proteins and histone-DNA interactions; induces G2/M cell cycle arrest in cancer cells; enhances p53 levels and activates the mitochondrial apoptotic pathway, leading to cytochrome c release and caspase-9 activation.